Skagit Organics

A long running rulemaking project got fresh feedback on a draft from those in the medical cannabis sector, but staff were no closer to being able to forecast completion of their work.

Participants offered feedback to DOH staff questions related to their medical cannabis testing requirements and then posed questions of their own to officials.

DOH staff heard stories and suggestions from patients, advocates, and other stakeholders on how to improve affordability, access, and understanding of medically compliant cannabis products.

Staff received more input on how draft agency request bills on contract growing for patients and advertising changes might potentially impact patients, businesses, and the cannabis market.

Unanimously supportive testimony on a bill to remove the cannabis excise tax for medical patients registered with the state called attention to problems around taxing medicine.

Testimony on a bill to exempt registered medical cannabis patients from the excise tax on DOH compliant products was supportive and elicited several questions from lawmakers.

Two visions for the future of cannabinoid regulation were presented to senators, with testimony split between a measure developed by WACA members and WSLCB request legislation.

A majority of speakers favored legislation to create a cannabis commodity commission, but questions remained about costs, goals, and the inclusiveness with which the bill was drafted.

Testimony on legislation establishing a limited excise tax exemption for medical cannabis patients registered with the State painted an encouraging picture of potential impacts for patients and the regulated industry.

Written testimony submitted regarding HB 1019, a bill dealing with adult cannabis cultivation, revealed a large amount of encouraging feedback and a couple of dissenting critiques.